In all, several studies both in humans and animal models point to GALNT2 as a contributing molecule to highly prevalent metabolic abnormalities, including atherogenic dyslipidemia, type 2 diabetes and obesity, which all impose a heavy burden for patients, their families and society as a whole. Here, GALNT2 is linked to metabolic syndrome.